What's new

Human medicines European public assessment report (EPAR): Invokana, canagliflozin, Date of authorisation: 15/11/2013, Revision: 26, Status: Authorised

Human medicines European public assessment report (EPAR): Invokana, canagliflozin, Date of authorisation: 15/11/2013, Revision: 26, Status: Authorised

Jun 13, 2025 - 13:45
 0
Human medicines European public assessment report (EPAR): Invokana, canagliflozin, Date of authorisation: 15/11/2013, Revision: 26, Status: Authorised
Human medicines European public assessment report (EPAR): Invokana, canagliflozin, Date of authorisation: 15/11/2013, Revision: 26, Status: Authorised
Read More

Tags:

Previous Article

More than 70 nutrition scientists call for freedom from censorship at NIH

Next Article

Houthis have previously used modified Scud missiles to strike Israel: Exclusive ...

Related Posts

Human medicines European public assessment report (EPAR): Fingolimod Accord, fingolimod, Date of authorisation: 25/06/2020, Revision: 9, Status: Authorised

Human medicines European public assessment report (EPAR...

May 16, 2025  0

Human medicines European public assessment report (EPAR): Kostaive, zapomeran, Date of authorisation: 12/02/2025, Revision: 1, Status: Authorised

Human medicines European public assessment report (EPAR...

May 23, 2025  0

Opinion/decision on a Paediatric investigation plan (PIP): Fasenra, Benralizumab, decision type: P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s), therapeutic area: Gastroentology-Hepatology, PIP number: P/0038/2022

Opinion/decision on a Paediatric investigation plan (PI...

May 20, 2025  0